Cargando…
Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy
The treatment of metastatic urothelial carcinoma has dramatically changed over the past decade with the approval of several therapies from multiple drug classes including immune checkpoint inhibitors, targeted therapies, and antibody drug conjugates. Although next generation sequencing of urothelial...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477976/ https://www.ncbi.nlm.nih.gov/pubmed/37675102 http://dx.doi.org/10.3389/fimmu.2023.1258388 |